Cost-effectiveness analysis of rezvilutamide versus bicalutamide in the treatment of metastatic hormone-sensitive prostate cancer

Objectives The economic implications of combining rezvilutamide with androgen deprivation therapy (ADT) remain uncertain, despite the observed survival advantages compared with bicalutamide plus ADT. Therefore, this study evaluates the cost-effectiveness of rezvilutamide plus ADT as the first-line t...

Full description

Bibliographic Details

Published in:	BMJ Open
Main Authors:	Haiying Ding, Luo Fang, Wenxiu Xin, Xinglu Xu, Shujing Li, Weiben Xu, Chaoneng He, ZhaJun Zhan
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-07-01
Online Access:	https://bmjopen.bmj.com/content/14/7/e073170.full